Zobrazeno 1 - 10
of 187
pro vyhledávání: '"J. Sleep"'
Publikováno v:
CIRED 2021 - The 26th International Conference and Exhibition on Electricity Distribution.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dda1ed51f42b99f7a5450e0c7d2c030
https://doi.org/10.1049/icp.2021.1631
https://doi.org/10.1049/icp.2021.1631
Autor:
Kamlesh M. Thakker, Aditya Lele, Anne C. Goldberg, Vera Bittner, Carolyn M. Setze, Darryl J. Sleep, Maureen T. Kelly, Carl J. Pepine
Publikováno v:
The American Journal of Cardiology. 107:898-905
The combination of fibrate and statin therapies may be a treatment option for women with multiple lipid abnormalities. We, therefore, initiated the present safety and efficacy analysis to address the paucity of such data in women with mixed dyslipide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b36aed2a0df34cfc6c8b8d59ae83a5
https://doi.org/10.1016/j.amjcard.2010.11.009
https://doi.org/10.1016/j.amjcard.2010.11.009
Autor:
Maureen T. Kelly, Peter B. Jones, James C. Stolzenbach, Carolyn M. Setze, Howard R. Knapp, Anne C. Goldberg, Darryl J. Sleep
Publikováno v:
American Heart Journal. 160:759-766
Statin and ezetimibe combination therapy may be insufficient to improve lipid and nonlipid parameters beyond low-density lipoprotein cholesterol (LDL-C) in patients with mixed dyslipidemia.In this phase 3, multicenter, double-blind study, a total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f5984c9674b2d26235730f1b86b650
https://doi.org/10.1016/j.ahj.2010.06.045
https://doi.org/10.1016/j.ahj.2010.06.045
Autor:
James M. McKenney, Carolyn M. Setze, Harold E. Bays, Katie Obermeyer, Darryl J. Sleep, Kamlesh M. Thakker, Eli M. Roth, Maureen T. Kelly
Publikováno v:
Diabetes Care
OBJECTIVE To compare fenofibric acid (FA) + statin to respective monotherapies on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemia. RESEARCH DESIGN AND METHODS Post hoc analysis of over 2,000 meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f049b9ab5762735e42dd32f09ab5707
https://doi.org/10.2337/dc10-0357
https://doi.org/10.2337/dc10-0357
Autor:
Carolyn M. Setze, James C. Stolzenbach, Maureen T. Kelly, Kamlesh Thakker, Kenneth Cusi, Michael H. Davidson, Darryl J. Sleep, Peter B. Jones
Publikováno v:
American Journal Cardiovascular Drugs. 10:73-84
Monotherapy with lipid-modifying medication is frequently insufficient to normalize lipid abnormalities in patients with mixed dyslipidemia and type 2 diabetes mellitus.To evaluate the efficacy and safety of fenofibric acid + statin combination thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2bfc1f651a7096aee8a6c26b2b3e015
https://doi.org/10.2165/10061630-000000000-00000
https://doi.org/10.2165/10061630-000000000-00000
Autor:
Susan M. Buttler, Darryl J. Sleep, Anne C. Goldberg, James C. Stolzenbach, Carolyn M. Setze, Peter B. Jones, Aditya Lele, Carl J. Pepine, Maureen T. Kelly, Michael H. Davidson
Publikováno v:
Journal of Clinical Lipidology. 3:125-137
Patients with mixed dyslipidemia often require combination therapy to manage multiple lipid abnormalities.To evaluate fenofibric acid in combination with a statin across three studies of patients with mixed dyslipidemia.As prospectively planned, data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3213e2f20efe827840abad19cf426cb
https://doi.org/10.1016/j.jacl.2009.02.007
https://doi.org/10.1016/j.jacl.2009.02.007
Autor:
Anne C. Goldberg, Harold E. Bays, Carolyn M. Setze, Susan M. Buttler, Darryl J. Sleep, Maureen T. Kelly, Christie M. Ballantyne, James C. Stolzenbach
Publikováno v:
The American Journal of Cardiology. 103:515-522
In patients with mixed dyslipidemia characterized by increased triglycerides (TG), decreased high-density lipoprotein (HDL) cholesterol, and increased low-density lipoprotein (LDL) cholesterol, monotherapy with lipid-altering drugs often fails to ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b04056c064e10780115af7c7cf95941
https://doi.org/10.1016/j.amjcard.2008.10.025
https://doi.org/10.1016/j.amjcard.2008.10.025
Autor:
Walid M. Awni, Balakrishna Hosmane, James C. Stolzenbach, Maureen T. Kelly, Darryl J. Sleep, Tong Zhu, Katty Wan, Titus Chira, Rajendra S. Pradhan
Publikováno v:
The Journal of Clinical Pharmacology. 49:63-71
ABT-335 is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia. ABT-335 and rosuvastatin have different mechanisms of actions and exert complementary pharmacodyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea6b926111d3e28afd6ef038c04fc2c
https://doi.org/10.1177/0091270008325671
https://doi.org/10.1177/0091270008325671
Autor:
Claude Schulman, Jeffrey D. Isaacson, Darryl J. Sleep, David P. Dearnaley, Fred Saad, Scott North, Joel B. Nelson, Michael A. Carducci, Per-Anders Abrahamsson
Publikováno v:
Cancer. 110:1959-1966
The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin-A receptor antagonist, in patients with metastatic hormone-refractory prostate cancer (HRPC).This multinational, double-blind, placebo-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5971a86a143fb896a6e85bfd89a0ce8
https://doi.org/10.1002/cncr.22996
https://doi.org/10.1002/cncr.22996
Publikováno v:
Archives of Disease in Childhood. 84:15-19
AIMS To estimate the financial cost to the NHS of infant crying and sleeping problems in the first 12 weeks of age and to assess the cost effectiveness of behavioural and educational interventions aimed at reducing infant crying and sleeping problems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76aae1c907c2cf3c33f7cbea5c778419
https://doi.org/10.1136/adc.84.1.15
https://doi.org/10.1136/adc.84.1.15